Alemtuzumab beta

DB33837ExperimentalProtein Based Therapies

Alemtuzumab beta: Overview.

Resolves to

Compound
ChEMBLCHEMBL5314722

Which companies are running trials of Alemtuzumab beta, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In